Boehringer Ingelheim and Priaxon Collaborates to Research and Develop Novel Treatments for Cancer

News   Jan 19, 2010

 
Boehringer Ingelheim and Priaxon Collaborates to Research and Develop Novel Treatments for Cancer
 
 
 

RELATED ARTICLES

University of Huddersfield Honorary Award Goes to RSC’s First Woman President

News

The first woman President of the Royal Society of Chemistry, Professor Lesley Yellowlees, will collect an honorary award from University of Huddersfield, which will be presented at the University’s November Award Ceremonies.

READ MORE

Drug Discovery Alliance Formed to Help Increase Drug Development Success Rate

News

Two prominent preclinical safety companies have launched a unique European alliance to address the high safety-related failure rate in drug development.

READ MORE

First Ever Online Event Focused on Cannabis Science

News

Analytical Cannabis is pleased to announce that the final line-up of speakers for the first ever cannabis science online event, The Science of Cannabis 2017 has been confirmed.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE